Ontario Virtual Medical Isotopes Mission 2021 to the U.S.
Business Program
9:15 AM – 12:55 PM
Conference: Unleashing Partnerships & Collaboration Opportunities in Medical Isotopes
9:15 AM – 9:20 AM
Opening Remarks
James Scongack
Chair of the Canadian Nuclear Isotope Council (CNIC)
9:20 AM – 9:25 AM
Welcome Remarks by Minister Fedeli, Ministry of Economic Development, Job Creation and Trade
9:25 AM – 10:15 AM
Panel 1: Research and Development: A discussion about opportunities for collaboration and translation activities to support and advance the medical isotope sector.
Moderator: Marie – Claude Gregoire, Head of Directorate, Isotopes, Canadian Nuclear Labs
- Marie-Claude Gregoire
Head of Directorate, Isotopes, Canadian Nuclear Labs - Susan Hogle
Radioisotope Portfolio Manager, Oak Ridge National Labs - Andrea Armstrong
Research Scientist, McMaster University - Steve Biegalski
Chair of Nuclear and Radiological Engineering and Medical Physics Program at Georgia Institute of Technology
10:15 AM – 11:05 AM
Panel 2: Medical Isotope Production: A discussion on irradiation and enrichment capabilities
Moderator: Terry Campkin, Sr. Manager, Materials and Inventory, OPG
- James Harvey
Chief Science Officer at NorthStar Medical Radioisotopes - Maia Ingram
Program Manager, Isotopes & Business Development, Bruce Power - Matt Sanford
Associate Director, Products and Services, MU Research Reactor - Terry Campkin
Sr. Manager Materials and Inventory, OPG
11:05 AM - 11:10 AM
Remarks by Minister Smith, Ministry of Energy (MoE)
11:10 AM – 12:00 PM
Panel 3: Medical Isotope Processing: A discussion on the post irradiation handling of medical isotopes to support patients – facilities and capabilities
Moderator: Kathryn Hayashi, CEO, TRIUMF
- Martyn Coombs
President, BWXT - Ira Goldman
Vice President, Global Public Policy and Government Relations, Lantheus - Kathryn Hayashi
CEO, TRIUMF - Jehanne Gillo
Director, Facilities and Project Management Division, Department of Energy
12:00 PM – 12:50 PM
Panel 4: Reactor, Supply Chain & Support Services Opportunities: A discussion on the supporting medical isotope ecosystem from isotopes to radiopharmaceuticals
Moderator: Joe McCann, Chief Executive Officer, Point Biopharma
- Travis Besanger
Technical and Business Director, Isogen - Joe McCann
Chief Executive Officer, Point Biopharma - Bud Albright
President and CEO, United States Industry Council - Phil Sharpe
VP, Innovation and Special Projects at Studsvik Scandpower - Jim Wilson
Global Director of Materials Management Eckert and Ziegler Isotope Products
12:50 PM – 12:55 PM
Closing Remarks by Brian Fehrenbach, Director of Business Development and SMR Supply Chain Development, Organization of Canadian Nuclear Industries (OCNI)